Manifestation of adrenocortical insufficiency following levothyroxine administration in a patient with polyglandular autoimmune syndrome type II (Schmidt's syndrome);Manifestation einer nebennierenrindeninsuffizienz nach gabe von levothyroxin bei einem patienten mit polyglandularem autoimmunsyndrom typ II (Schmidt-syndrom)

Internist

Volumn 41, Issue 6, 2000, Pages 588-591

  Canbay, A ^a   Gieseler, R ^b   Ella, R ^b   Fink, H ^b   Saller, B ^b   Mann, K ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE;

ADRENAL CORTEX FUNCTION; ADRENAL CORTEX INSUFFICIENCY; ARTICLE; GERMANY; HUMAN; MULTIPLE ENDOCRINE ADENOMATOSIS; SCHMITT SYNDROME;

EID: 0033918937     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050564     Document Type: Article

References (25)

1. 1. Leshin M (1985) Polyglandular autoimmune syndromes. Am J Med Sci 290:77-88
2. 2. Neufeld M, MacLaren N, Blizzard R (1981) Two types of autoimmune Addison's disease associated with different polyglandular autoimmune syndromes. Medicine 60:355-362
3. 3. Neufeld M, MacLaren N, Blizzard R (1980) Autoimmune polyglandular syndromes. Pediatr Ann 9:154-162
4. 4. Schmidt MB (1926) Eine biglanduläre Erkrankung (Nebennieren und Schilddrüse) bei Morbus Addisonii. Verh Dtsch Ges Pathol 21:212-221
5. 5. Rothenberg ME (1998) Mechanisms of disease: Eosinophilia. N Engl J Med 338:1592-1600
6. 6. Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH (1997) Susceptibility and resistance allels of human leukocyte (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80:2112-2117
7. 7. Dluhy RG (1996) The adrenal cortex in hypothyroidism. In: Werner, Ingbar (Hrsg) The thyroid, 7th edn, pp 841-844
8. 8. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Zanchetta R, Greggio NA, Pedini B, Boscaro M, Presotto F (1997) II Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organic-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 82:939-942
9. 9. Betterle C, Volpato M, Rees Smith B, Furmaniak J, Chen S, Greggio NA, Sanzari M, Tedesco F, Pedini B, Boscaro M, Presotto F (1997) I Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organic-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab 82:932-938
10. 10. Tosti A, Allopecia areata (1989) More on pathogenesis and therapy. Dermatologica 178:61-63
11. 11. Luster AD (1998) Mechanisms of disease: chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445
12. 12. Mosman TR, Coffmann RI (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
13. 13. Peters JH, Gieseler R, Thiele B, Steinbach F (1996) Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunology Today 17:273-278
14. 14. Bigazzi PE (1985) Autoimmune thyroid disease. In: Rose NR, Macky IR (Hrsg) The autoimmune disease. Academic Press, New York: 161-199
15. 15. Satoh J, Problakar BS, Haspel MV et al. (1983) Human monoclonal antibodies that react with multiple endocrine organs. N Engl J Med 309:217-220
16. 16. Topliss D, How J, Lewis M et al. (1983) Evidence for cell-mediated immunity and specific suppressor T-lymphocyte dysfunction in Graves' disease and diabetes mellitus. J Clin Endocrinol Metab 57:700-705
17. 17. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Smith BR, Furmaniak J (1996) Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 81:1871-1876
18. 18. Falorni A, Nikoshkov A, Laureti S, Grenbäck E, Hulting AL, Casucci G, Santeusanio F, Brunetti P, Luthman H, Lernmark A (1995) High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-Hydroxylase. J Clin Endocrinol Metab 80:2752-2755
19. 19. Hidaka Y, Okumura M, Shimaoka Y, Takeoka K, Tada H, Amino N (1998) Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis. Thyroid 8:235-239
20. 20. Kaufmann SHE (1997) Immunität gegen intrazelluläre Bakterien. Die Gelben Hefte 37:97-113
21. 21. Häberle M, Kerscher M, Freitag M (1998) Hauterkrankungen durch physikalische und chemische Noxen, Pigmentierungsstörungen. In: Altmeyer P, Dirschka T, Hartwig R (Hrsg) Klinikleitfaden Dermatologie. Fischer, Ulm Stuttgart Jena Lübeck, S 304-305
22. 22. Pfannenstiel P, Saller B, Hotze LA (1997) Schilddrüsenkrankheiten: Diagnose und Therapie. Berliner Med Verl-Anst, Berlin
23. 23. Kolb E (1993) Einige neuere Erkentnisse zur Pathobiochemie und Pathophysiologie des M. Cushing und des M. Addison beim Hund. Mh Vet-Med 48:523-530
24. 24. Wehling M, Theisen K (1990) Extrarenal receptor-effector-mechanisms for aldosterone: the sequence of effects on the cellular electrolyte transport in human lymphocytes and their implications for disorder of the water and electrolyte balances. Acta Endocrina 123:384-394
25. 25. Winquist O, Söderbergh A, Kampe O (1996) The autoimmune basis of adrenocortical destruction in Addison's disease. Molecular Medicine Today 7:282-289